Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2015 035 998.4 |
96 | EP file number | EAKZ | 15 83 9636.6 |
86 | WO file number | WAKZ | PCT/JP2015/075567 |
97 | EP publication number | EPN | 3192512 |
87 | WO publication number | WPN | 2016039367 |
54 | Designation/title | TI | NEUARTIGE PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR HARNINKONTINENZPRÄVENTION UND/ODER BEHANDLUNG |
51 | IPC main class | ICM (ICMV) | A61K 31/506 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 13/02 (2006.01), C07D 401/14 (2006.01) |
22 | DE application date | DAT | Sep 9, 2015 |
96 | EP application date | EAT | Sep 9, 2015 |
86 | WO application date | WAT | Sep 9, 2015 |
43 | Date of first publication | OT | Mar 17, 2016 |
| Date of publication of grant | PET | Aug 14, 2019 |
71/73 | Applicant/owner | INH | Cytokinetics, Inc., South San Francisco, CA, US |
72 | Inventor | IN | MORI, Shinobu, Tokyo 103-8411, JP; KAJIHARA, Yusuke, Tokyo 103-8411, JP; INAMURA, Hiroko, Tokyo 103-8411, JP; HIRATA, Takuya, Tokyo 103-8411, JP |
74 | Representative | VTR | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
| Address for service | | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| JP 2014183434 Sep 9, 2014
|
| Due date | FT FG | Sep 30, 2024 Annual fee for the 10th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003192512A1 Searchable text:
EP000003192512A1 Original document:
EP000003192512B1 Searchable text:
EP000003192512B1 Original document:
WO002016039367 Searchable text:
WO002016039367 |
43 | Date of first publication | EVT | Mar 17, 2016 |
| Date of the first transfer into DPMAregister | EREGT | Jul 20, 2017 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 8, 2024 (Show all update days)(Hide all update days)- Oct 8, 2024
- Procedures: Procedure relating to PCT application, Publication of PCT application, 17.03.2016: deleted
- Jul 21, 2023; Jun 24, 2022; Jan 25, 2022; Jan 6, 2022; Jul 31, 2021; Sep 9, 2020; Aug 6, 2020; Jul 23, 2020; Oct 26, 2019; Sep 26, 2019; Aug 23, 2019; Jul 25, 2019; Sep 1, 2017
- Historical data not available for this/these date(s)
- Jul 20, 2017
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 8)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jan 5, 2022 |
| Issue number | HN | 7 |
| Year | PJ | 2022 |
| Publication date | VT | Feb 17, 2022 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Cytokinetics, Inc., South San Francisco, CA, US |
71/73 | Previous applicant/owner | INHF | Astellas Pharma Inc., Tokyo, JP, Cytokinetics, Inc., South San Francisco, Calif., US |
| Date of update of the procedure | REGT | Jan 25, 2022 |